Thinking
The FDA’s GenAI-device paper is a question set, not a compliance checklist
FDA is considering a competency-based evaluation model for generative-AI medical devices. Its discussion paper offers diligence questions about the finished device, intended use, clinical confirmation, and postmarket monitoring—not adopted requirements.
Super Genius Labs Editorial · Aug 23, 2026 · 4 min readThinkingWhat evidence should healthcare AI operators retain for non-device software?
FDA’s patient-safety inquiry gives healthcare AI operators a bounded prompt: preserve intended use, observed benefits, safety signals, implementation lessons, governance practices, and evidence ownership without treating an operational record as a legal classification or proof of safety.
Super Genius Labs Editorial · Aug 13, 2026 · 4 min read